Balaji Amines Past Earnings Performance
Past criteria checks 2/6
Balaji Amines's earnings have been declining at an average annual rate of -18.5%, while the Chemicals industry saw earnings growing at 6.5% annually. Revenues have been declining at an average rate of 8.2% per year. Balaji Amines's return on equity is 7.9%, and it has net margins of 11.7%.
Key information
-18.47%
Earnings growth rate
-18.47%
EPS growth rate
| Chemicals Industry Growth | 17.68% |
| Revenue growth rate | -8.16% |
| Return on equity | 7.86% |
| Net Margin | 11.73% |
| Last Earnings Update | 31 Mar 2026 |
Recent past performance updates
Recent updates
Narrative Update • Jul 09
530999: Higher Future P E Will Support Returns Despite Slight Margin Pressure
Analysts have raised their fair value estimate for Balaji Amines from ₹1,494 to ₹3,327, citing revised assumptions on the discount rate, revenue growth, profit margin and forward P/E as the key drivers of the updated price target. What’s in the News for Balaji Amines Balaji Amines has scheduled a Board Meeting on May 13, 2026.Narrative Update • Jun 18
530999: Higher P E And Weaker Margins Will Pressure Future Returns
Analysts have raised their price target on Balaji Amines to ₹1,494 from ₹1,334, reflecting updated assumptions for revenue growth, profit margins and future P/E expectations. What’s in the News for Balaji Amines Balaji Amines has scheduled a board meeting for May 13, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.Narrative Update • May 21
530999: Lower Multiple Expectations Will Drive Cautious View Despite Margin Optimism
Analysts have trimmed their fair value estimate for Balaji Amines from ₹1,561 to ₹1,334, citing updated assumptions around revenue growth, profit margins and future P/E expectations. What's in the News Board meeting scheduled for May 13, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 (Key Developments) Board to consider recommending a final dividend on equity shares for the financial year ended March 31, 2026, subject to shareholder approval at the 38th Annual General Meeting (Key Developments) Matters related to the upcoming 38th Annual General Meeting, including formal approvals and shareholder items, are also on the board meeting agenda (Key Developments) Valuation Changes Fair Value: Trimmed from ₹1,561 to ₹1,334, indicating a lower central estimate for the stock's worth based on updated assumptions.
Narrative Update • May 07
530999: Higher Assumed Margins And P E Multiple Will Likely Limit Upside
Analysts have maintained their price target for Balaji Amines at ₹1,334. This reflects updated views based on a slightly lower discount rate, a modestly higher assumed revenue growth of 21.69% and a profit margin of 14.49%, as well as a revised future P/E assumption of 18.64x.
Narrative Update • Apr 23
530999: Higher Revenue Outlook And Lean Margins Will Support Future Upside
Analysts have trimmed their price target for Balaji Amines from ₹1,616.67 to ₹1,447.50, reflecting updated assumptions around discount rate, revenue growth, profit margin, and future P/E. Valuation Changes Fair Value: Trimmed from ₹1,616.67 to ₹1,447.50, indicating a lower central estimate for the share price.Narrative Update • Apr 08
530999: Higher Margin Outlook And Upcoming Results Will Support Bullish Repricing
Analysts have kept the price target for Balaji Amines steady at ₹1,561, citing slightly adjusted assumptions on the discount rate, revenue growth, profit margin and forward P/E as the main factors behind the unchanged view. What's in the News A board meeting is scheduled for January 29, 2026 to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025 (Key Developments).Narrative Update • Mar 24
530999: Refined Margins And P E Assumptions Will Likely Support Returns
Analysts have maintained their fair value estimate for Balaji Amines at ₹1,334. The steady price target is supported by only small adjustments to the discount rate, revenue growth assumptions, profit margin and future P/E expectations.Narrative Update • Mar 10
530999: Refined Margins And P E Assumptions Will Likely Support Returns
Analysts have kept their fair value estimate for Balaji Amines steady at ₹1,334, with small refinements to the discount rate, revenue growth, profit margin and future P/E assumptions guiding this unchanged price target. What's in the News A board meeting is scheduled on Jan 29, 2026 to consider, approve and take on record the unaudited standalone and consolidated financial results for the quarter and nine months ended Dec 31, 2025 (company filing).Narrative Update • Feb 23
530999: Higher Future P E And Margins Will Likely Support Returns
Analysts have maintained their price target for Balaji Amines at ₹1,334, reflecting a balance between a lower discount rate, slightly adjusted revenue growth assumptions, a modestly higher profit margin outlook, and a marginally higher future P/E multiple. What's in the News Board meeting scheduled for January 29, 2026, to review and approve the unaudited standalone financial results for the quarter and nine months ended December 31, 2025.Narrative Update • Feb 09
530999: Higher Margin Outlook And Upcoming Results Will Support Bullish Repricing
Analysts have revised their price target for Balaji Amines from ₹2,331 to ₹1,561, reflecting updated views on a lower assumed revenue growth rate, a slightly higher discount rate, a higher profit margin, and a reduced future P/E multiple. What's in the News Board meeting scheduled for Jan 29, 2026, to review and approve the unaudited standalone financial results for the quarter and nine months ended Dec 31, 2025 (Key Developments).Narrative Update • Jan 25
530999: Richer Forward P/E Will Likely Support Returns Despite Thinner Margins
Analysts have raised their price target for Balaji Amines from ₹1,185 to ₹1,334, reflecting revised assumptions of higher revenue growth and a richer forward P/E multiple, partly offset by a lower profit margin outlook and a slightly higher discount rate. What's in the News Board meeting scheduled on Jan 29, 2026, to consider, approve and take on record the unaudited standalone and consolidated financial results for the quarter and nine months ended Dec 31, 2025 (company filing).Narrative Update • Jan 10
530999: Stable Margins And Upcoming Results Will Support Further Upside
Analysts have maintained their price target for Balaji Amines at ₹1,616.67, reflecting largely unchanged assumptions on the discount rate, revenue growth, profit margin and future P/E. What's in the News A board meeting is scheduled for November 10, 2025, to consider and approve the unaudited standalone financial results for the quarter and half year ended September 30, 2025 (company filing).Narrative Update • Dec 25
530999 Will Likely See Slower Expansion Offset By Stronger Profit Margins
Analysts have reduced their fair value estimate for Balaji Amines to ₹1,185 from ₹1,598, citing expectations of slower revenue growth and a lower future P E multiple. This is partially offset by improved projected profit margins and a slightly higher discount rate.Narrative Update • Dec 11
530999: Stable Margins And Growth Outlook Will Support Further Upside
Analysts have modestly lifted their price target on Balaji Amines to ₹1,616.67 per share, reflecting slightly higher assumed discount rates and steady long term growth and margin expectations that together support a marginally richer valuation multiple. What's in the News Board meeting scheduled on November 10, 2025 to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (company filing).Narrative Update • Nov 27
530999: Rising Profit Margins Will Drive Further Upside Despite Slower Sales
Analysts have revised their price target for Balaji Amines downward from ₹1,847 to ₹1,617. This change is due to expectations of slower revenue growth, even though profit margin projections have improved.Narrative Update • Sep 05
New Plant Launches And Certifications Set To Drive Future Operational Efficiency And Revenue Potential
With both the Future P/E and Discount Rate showing only marginal changes, analysts have effectively maintained their valuation outlook for Balaji Amines, resulting in an unchanged consensus price target of ₹1847. What's in the News Board meeting scheduled to consider and approve un-audited standalone and consolidated financial results for the quarter ended 30 June 2025.
New Narrative • Feb 02
New Plant Launches And Certifications Set To Drive Future Operational Efficiency And Revenue Potential
New plant expansions and strategic focus on high-margin products promise revenue growth and improved net margins through enhanced efficiency and diversification.Revenue & Expenses Breakdown
Revenue & Expenses Breakdown
How Balaji Amines makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 26 | 14,250 | 1,672 | 842 | 0 |
| 31 Dec 25 | 13,829 | 1,441 | 813 | 0 |
| 30 Sep 25 | 13,643 | 1,458 | 816 | 0 |
| 30 Jun 25 | 13,707 | 1,522 | 815 | 0 |
| 31 Mar 25 | 13,971 | 1,575 | 802 | 0 |
| 31 Dec 24 | 14,583 | 1,855 | 828 | 0 |
| 30 Sep 24 | 15,289 | 2,017 | 848 | 0 |
| 30 Jun 24 | 15,626 | 1,954 | 848 | 0 |
| 31 Mar 24 | 16,415 | 2,049 | 833 | 0 |
| 31 Dec 23 | 16,990 | 1,842 | 761 | 0 |
| 30 Sep 23 | 19,019 | 1,974 | 751 | 0 |
| 30 Jun 23 | 21,489 | 2,553 | 771 | 0 |
| 31 Mar 23 | 23,554 | 3,255 | 855 | 0 |
| 31 Dec 22 | 26,652 | 3,868 | 1,050 | 0 |
| 30 Sep 22 | 26,451 | 4,138 | 1,093 | 0 |
| 30 Jun 22 | 25,433 | 4,010 | 1,077 | 0 |
| 31 Mar 22 | 23,229 | 3,684 | 969 | 0 |
| 31 Dec 21 | 19,598 | 3,442 | 896 | 0 |
| 30 Sep 21 | 17,844 | 3,296 | 850 | 0 |
| 30 Jun 21 | 15,411 | 2,956 | 809 | 0 |
| 31 Mar 21 | 13,133 | 2,382 | 735 | 0 |
| 31 Dec 20 | 11,592 | 1,845 | 477 | 0 |
| 30 Sep 20 | 9,946 | 1,329 | 429 | 0 |
| 30 Jun 20 | 9,395 | 1,186 | 392 | 0 |
| 31 Mar 20 | 9,395 | 1,048 | 557 | 0 |
| 31 Dec 19 | 9,095 | 1,000 | 328 | 0 |
| 30 Sep 19 | 9,214 | 1,029 | 304 | 0 |
| 30 Jun 19 | 9,319 | 1,036 | 312 | 0 |
| 31 Mar 19 | 9,468 | 1,175 | 332 | 0 |
| 31 Mar 18 | 8,644 | 1,132 | 296 | 0 |
| 31 Mar 17 | 6,730 | 824 | 266 | 0 |
| 31 Mar 16 | 6,446 | 576 | 233 | 0 |
Quality Earnings: 530999 has a high level of non-cash earnings.
Growing Profit Margin: 530999's current net profit margins (11.7%) are higher than last year (11.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 530999's earnings have declined by 18.5% per year over the past 5 years.
Accelerating Growth: 530999's earnings growth over the past year (6.1%) exceeds its 5-year average (-18.5% per year).
Earnings vs Industry: 530999 earnings growth over the past year (6.1%) did not outperform the Chemicals industry 14%.
Return on Equity
High ROE: 530999's Return on Equity (7.9%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/17 12:19 |
| End of Day Share Price | 2026/07/17 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2026/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Balaji Amines Limited is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Nilesh Ghuge | HDFC Securities Limited |
| Jay Gandhi | HDFC Securities Limited |
| Keshav Lahoti | HDFC Securities Limited |